viewOpen Orphan PLC

Venn Life Sciences Holdings PLC beat forecasts on rising contract sizes, says chief

Venn Life Sciences Holdings PLC (LON:VENN) has forecast better-than-expected annual results after winning bigger contracts this year.

Tony Richardson, chief executive, tells Proactive Investors the company has “moved from the realm of a typical contract size being €300,000/€400,000/€500,000 per piece,” to “a pipeline that has a lot more multi million euro pieces of business in it.”

He says the company is seeing a “healthy mix” of both recurring revenue from existing clients as well as a “nice pattern” of referrals or recommendations from existing customers to new potential clients.

Quick facts: Open Orphan PLC

Price: 23.27 GBX

Market: AIM
Market Cap: £155.44 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...


Open Orphan first half: 'period of integration, restructuring and setting...

Proactive Analyst Emma Ulker talks through how Open Orphan (LON:ORPH) performed in the first half of the year.  In the six-month period to June 2020, the company focused on integration and restructuring following its acquisition of lab services and challenge studies specialist hVIVO in...

on 30/9/20

2 min read